Stock ABUS ARBUTUS BIOPHARMA CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Arbutus Biopharma Corporation

Equities

ABUS

CA03879J1003

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
3.36 USD +1.20% Intraday chart for Arbutus Biopharma Corporation +2.13% +34.40%
May. 20 Whitefort Capital Management Sends an Open Letter to Shareholders of Arbutus Biopharma CI
May. 17 Sector Update: Health Care Stocks Mixed Late Afternoon MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Arbutus to Participate in Jefferies Global Healthcare Conference
Arbutus to Present Imdusiran Data at EASL Congress 2024
Arbutus to Present Imdusiran Data at EASL Congress 2024
Whitefort Capital Publishes Open Letter to Arbutus Biopharma Shareholders Outlining Paths to Maximize Value
Whitefort Capital Management Sends an Open Letter to Shareholders of Arbutus Biopharma
Sector Update: Health Care Stocks Mixed Late Afternoon
Sector Update: Health Care Stocks Softer Friday Afternoon
Arbutus Biopharma Urged to Stop Share Issuances, Explore Alternatives for Hepatitis B Program
Arbutus Biopharma Urged to Stop Share Issuances, Explore Alternatives for Hepatitis B Program
Whitefort Capital Publishes Open Letter to Arbutus Biopharma Shareholders Outlining Paths to Maximize Value
Whitefort Capital Publishes Open Letter to Arbutus Biopharma Shareholders
Investor Whitefort urges Arbutus Biopharma to halt stock sales, find partner
Whitefort Capital Management Engages with Arbutus Biopharma
Arbutus to Participate in Two Upcoming Investor Conferences
Arbutus Biopharma : Corporate Presentation - May 2024
Transcript : Arbutus Biopharma Corporation, Q1 2024 Earnings Call, May 02, 2024
Earnings Flash (ABUS) ARBUTUS BIOPHARMA CORPORATION Posts Q1 Revenue $1.5M
Earnings Flash (ABUS) ARBUTUS BIOPHARMA CORPORATION Posts Q1 Revenue $1.5M, vs. Street Est of $3.7M
Arbutus: Q1 Earnings Snapshot
Arbutus Biopharma Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ABUS Stock
  4. News Arbutus Biopharma Corporation
  5. Other languages